These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12719275)

  • 21. Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis.
    Biecker E; Neef M; Sägesser H; Shaw S; Koshy A; Reichen J
    Liver Int; 2004 Aug; 24(4):345-53. PubMed ID: 15287858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of kaempferol against endothelial damage by an improvement in nitric oxide production and a decrease in asymmetric dimethylarginine level.
    Xiao HB; Jun-Fang ; Lu XY; Chen XJ; Chao-Tan ; Sun ZL
    Eur J Pharmacol; 2009 Aug; 616(1-3):213-22. PubMed ID: 19549512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated expression of caveolin-1 at protein and mRNA level in human cirrhotic liver: relation with nitric oxide.
    Yokomori H; Oda M; Yoshimura K; Nomura M; Wakabayashi G; Kitajima M; Ishii H
    J Gastroenterol; 2003; 38(9):854-60. PubMed ID: 14564631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central insulin regulates heart rate and arterial blood flow: an endothelial nitric oxide synthase-dependent mechanism altered during diabetes.
    Cabou C; Cani PD; Campistron G; Knauf C; Mathieu C; Sartori C; Amar J; Scherrer U; Burcelin R
    Diabetes; 2007 Dec; 56(12):2872-7. PubMed ID: 17804761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A defect of neuronal nitric oxide synthase increases xanthine oxidase-derived superoxide anion and attenuates the control of myocardial oxygen consumption by nitric oxide derived from endothelial nitric oxide synthase.
    Kinugawa S; Huang H; Wang Z; Kaminski PM; Wolin MS; Hintze TH
    Circ Res; 2005 Feb; 96(3):355-62. PubMed ID: 15637297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial effects of rosuvastatin on aortic adverse remodeling in nitric oxide-deficient rats.
    Neto-Ferreira R; Novaes Rocha V; da Silva Torres T; Mandarim-de-Lacerda CA; de Carvalho JJ
    Exp Toxicol Pathol; 2011 Jul; 63(5):473-8. PubMed ID: 20537513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice.
    Vinh A; Widdop RE; Drummond GR; Gaspari TA
    Cardiovasc Res; 2008 Jan; 77(1):178-87. PubMed ID: 18006471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: lessons from endothelin-1 transgenic/endothelial nitric oxide synthase knockout mice.
    Quaschning T; Voss F; Relle K; Kalk P; Vignon-Zellweger N; Pfab T; Bauer C; Theilig F; Bachmann S; Kraemer-Guth A; Wanner C; Theuring F; Galle J; Hocher B
    J Am Soc Nephrol; 2007 Mar; 18(3):730-40. PubMed ID: 17287431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2.
    Kilic U; Bassetti CL; Kilic E; Xing H; Wang Z; Hermann DM
    Neuroscience; 2005; 134(3):901-6. PubMed ID: 16009498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction.
    Massion PB; Dessy C; Desjardins F; Pelat M; Havaux X; Belge C; Moulin P; Guiot Y; Feron O; Janssens S; Balligand JL
    Circulation; 2004 Oct; 110(17):2666-72. PubMed ID: 15492314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of geranylgeranylation by rosuvastatin upregulates eNOS expression in human venous endothelial cells.
    Landsberger M; Jantzen F; Könemann S; Felix SB
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1005-9. PubMed ID: 16165089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-acting calcium channel blocker, azelnidipine, increases endothelial nitric oxide synthase in the brain and inhibits sympathetic nerve activity.
    Kimura Y; Hirooka Y; Sagara Y; Sunagawa K
    Clin Exp Hypertens; 2007 Jan; 29(1):13-21. PubMed ID: 17190727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute and chronic stress influence blood pressure variability in mice.
    Farah VM; Joaquim LF; Bernatova I; Morris M
    Physiol Behav; 2004 Oct; 83(1):135-42. PubMed ID: 15501500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normal vascular development in mice deficient in endothelial NO synthase: possible role of neuronal NO synthase.
    Al-Shabrawey M; El-Remessy A; Gu X; Brooks SS; Hamed MS; Huang P; Caldwell RB
    Mol Vis; 2003 Oct; 9():549-58. PubMed ID: 14551528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of in vivo cardiac function by myocyte-specific nitric oxide synthase-3.
    Champion HC; Georgakopoulos D; Takimoto E; Isoda T; Wang Y; Kass DA
    Circ Res; 2004 Mar; 94(5):657-63. PubMed ID: 14752030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of rapamycin on the arterial inflammatory response in atherosclerotic plaques in Apo-E knockout mice.
    Naoum JJ; Woodside KJ; Zhang S; Rychahou PG; Hunter GC
    Transplant Proc; 2005 May; 37(4):1880-4. PubMed ID: 15919492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases.
    Khan SA; Skaf MW; Harrison RW; Lee K; Minhas KM; Kumar A; Fradley M; Shoukas AA; Berkowitz DE; Hare JM
    Circ Res; 2003 Jun; 92(12):1322-9. PubMed ID: 12764022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Paul A; Ko KW; Li L; Yechoor V; McCrory MA; Szalai AJ; Chan L
    Circulation; 2004 Feb; 109(5):647-55. PubMed ID: 14744975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone receptor deficiency in mice results in reduced systolic blood pressure and plasma renin, increased aortic eNOS expression, and altered cardiovascular structure and function.
    Egecioglu E; Andersson IJ; Bollano E; Palsdottir V; Gabrielsson BG; Kopchick JJ; Skott O; Bie P; Isgaard J; Bohlooly-Y M; Bergström G; Wickman A
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1418-25. PubMed ID: 17244725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.